MONOPHARMAPharmaceuticals
Mono Pharmacre Ltd — Cash Flow Statement
₹11.15
-4.70%
Mono Pharmacre Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -4.53 Cr | -8.95 Cr | -28.62 Cr | 0.23 Cr | — |
| Issuance Of Capital Stock | 0.00 | 12.29 Cr | 12.37 Cr | 0.23 Cr | — |
| Capital Expenditure | -0.23 Cr | -0.18 Cr | -0.86 Cr | -0.01 Cr | — |
| End Cash Position | 0.70 Cr | 0.36 Cr | 0.42 Cr | 0.24 Cr | — |
| Beginning Cash Position | 0.36 Cr | 0.42 Cr | 0.00 | 0.17 Cr | — |
| Changes In Cash | 0.33 Cr | -0.06 Cr | 0.42 Cr | 0.07 Cr | — |
| Financing Cash Flow | 4.86 Cr | 8.32 Cr | 29.61 Cr | -0.15 Cr | — |
| Net Other Financing Charges | 0.05 Cr | — | 13000.00 | — | — |
| Interest Paid Cff | -4.03 Cr | -3.08 Cr | -0.77 Cr | -0.74 Cr | — |
| Net Common Stock Issuance | 0.00 | 12.29 Cr | 12.37 Cr | 0.23 Cr | — |
| Common Stock Issuance | 0.00 | 12.29 Cr | 12.37 Cr | 0.23 Cr | — |
| Net Issuance Payments Of Debt | 8.84 Cr | -0.89 Cr | 18.01 Cr | 0.36 Cr | — |
| Net Long Term Debt Issuance | 8.84 Cr | -0.89 Cr | 18.01 Cr | 0.53 Cr | — |
| Investing Cash Flow | -0.23 Cr | 0.40 Cr | -1.44 Cr | -0.01 Cr | — |
| Net Investment Purchase And Sale | 0.00 | 0.57 Cr | -0.57 Cr | 0.00 | — |
| Sale Of Investment | 0.00 | 0.57 Cr | — | — | — |
| Net PPE Purchase And Sale | -0.23 Cr | -0.18 Cr | -0.86 Cr | -0.01 Cr | — |
| Operating Cash Flow | -4.30 Cr | -8.77 Cr | -27.75 Cr | 0.24 Cr | — |
| Taxes Refund Paid | -1.39 Cr | -0.73 Cr | -0.20 Cr | -0.08 Cr | — |
| Change In Working Capital | -11.53 Cr | -14.47 Cr | -29.50 Cr | -1.09 Cr | — |
| Change In Other Current Liabilities | 6.91 Cr | 1.84 Cr | 23.67 Cr | -0.02 Cr | — |
| Change In Other Current Assets | 0.33 Cr | -0.41 Cr | -0.79 Cr | 0.03 Cr | — |
| Change In Payable | 9.11 Cr | 2.93 Cr | 6.78 Cr | 2.09 Cr | — |
| Change In Inventory | -13.09 Cr | -9.61 Cr | -32.69 Cr | -0.57 Cr | — |
| Change In Receivables | -15.72 Cr | -9.08 Cr | -27.22 Cr | -2.64 Cr | — |
| Other Non Cash Items | 4.03 Cr | 3.08 Cr | 0.77 Cr | 0.74 Cr | — |
| Depreciation And Amortization | 0.13 Cr | 0.12 Cr | 0.05 Cr | 0.11 Cr | — |
| Depreciation | 0.13 Cr | 0.12 Cr | 0.05 Cr | 0.11 Cr | — |
| Net Income From Continuing Operations | 4.46 Cr | 3.23 Cr | 0.93 Cr | 0.55 Cr | — |
| Net Other Investing Changes | — | 1000.00 | — | — | — |
| Amortization Cash Flow | — | 19000.00 | — | — | — |
| Repurchase Of Capital Stock | — | — | -0.27 Cr | — | — |
| Other Cash Adjustment Outside Changein Cash | — | — | -1000.00 | -1000.00 | — |
| Common Stock Payments | — | — | -0.27 Cr | — | — |
| Net Short Term Debt Issuance | — | — | 19.68 Cr | -0.17 Cr | -0.60 Cr |
| Purchase Of Investment | — | — | -0.57 Cr | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Mono Pharmacre Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.